Similarly, inhibiting the activity or decreasing the expression levels of particular DUBs including OTULIN and USP19, but also the CHIP inhibiting protein HspBP1 or the ligase WWP1, might be a strategy to reduce or prevent HD progression by improving proteasomal turnover. Here, WWP1 is linked to Huntington disease.